⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

LLY

Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,124.21USD

+0.2999 (+0.03%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 1,124.21
P/E37.5
Dvd Ind Yld0.6%
P/B29.59
P/S12.6
Curr EV/T12M EBITDA25.1
Mkt Cap (USD)1,002.5B
Curr EV (USD)1,047.8B
2)

Per Share Data

EPS T12M29.79
DPS6.47
Bk Val Per Sh38.00
Rev/Sh89.14
Cash/Sh10.04
Curr Shares Out891.7M
FCF/Sh6.56
3)

Cash Flow Analysis

P/CF35.7
Curr P/FCF171.0
CF/NI1.1
Dvd P/O21.7%
Cash Gen/Cash Reqd3.8
Csh Dvd Cov4.9
CFO/Sales35.3%
Eff Interest Rate1.9%
4)

Growth Potential

Dil EPS 1Y Gr96.0%
Cap 1Y Gr44.1%
BPS 1Y Gr86.9%
R&D To Sales10.2%
Retention Rate78.3%
Rev 1Y Gr44.7%
FCF 1Y Gr—
Assets 1Y Gr42.9%
5)

Profitability

EBITDA41.7B
EBIT—
Operating Margin54.2%
Pretax Margin42.2%
Net Margin33.5%
ROA22.0%
ROE102.4%
ROC—
Asset Turnover0.66
6)

Structure

Current Ratio1.35
Quick Ratio0.68
Debt/Assets38.6%
Debt/Com Eq162.1%
Net Debt/EBITDA1.10
Tot Debt/Capital61.8%
Gross Margin83.4%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.